[1]
A. Korga, “Evaluation of the combined effects of doxorubicin and bortezomib on the human acute lymphoblastic leukemia cell line”, Curr. Issues Pharm. Med. Sci., vol. 32, no. 2, pp. 87–91, Jun. 2019, doi: 10.2478/cipms-2019-0017.